A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver

Study Overview

The primary question of interest is quantifying the relationship between Y-90 liver therapy and liver damage.

Study Description

The purpose of this study is to look at the safety of radioembolization therapy with Yttrium 90 for liver disease.

Additional Information

Participants will not be paid for their participation.

  • IRB Number: 1606072855 (RADY-BTG-TANN-HIDA/0603)
  • Research Study Identifier: TX7335
  • Principal Investigator: Mark Tann, MD

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at inhealth@iu.edu or by phone at (888) 264-0005.